Meet the "Core 4" of the 1994 Rangers Stanley Cup Champions this Sunday

Posted by Reeve Staff in Daily Dose on June 28, 2019 # Events

iPlay America in Freehold, NJ is having the “Core 4” of the 1994 Rangers Stanley Cup champions, Brian Leetch (#2), Adam Graves (#9), Mark Messier (#11) and Mike Richter (#35) for a Q&A Meet and Greet and Silent Auction event on Sunday, June 30. This event will benefit local Monroe High School hockey player, Mike Nichols, who was injured on the ice in 2014. The proceeds from the auction will go directly to the Nichols Family Trust to provide for Mike’s medical needs.

This exciting family-friendly event will offer a once in a lifetime opportunity, as “The Core 4” will speak of their memories as a crucial part of the 94’ Rangers Championship team, and answer your questions live. There will also be Rangers trivia with our professional narrator, and the chance to win prizes and enjoy videos of this classic Championship Game. At the end of the evening, the four players will auction off signed jerseys.

In January 2014, Nichols sustained a spinal cord injury during a varsity hockey game when he was checked from behind, fracturing his C5 vertebrae. Following the accident, the Monroe Township student received a flood of support from the hockey community, including the New Jersey Devils, as well as Boomer Esiason. Over five years later, Nichols now pays forward his gratitude by serving as an ambassador for the Christopher & Dana Reeve Foundation to help speed the development of treatments for spinal cord injury.

For the “Core 4” event, different level tickets are available, which include professional photos with the former NHL players, pre-signed commemorative event photo, and the opportunity to meet Jeff Beukeboom, Stephane Matteau and Alexei Kovalev during a pre-event reception at 12 pm. Tickets are available for purchase up until June 29.

The National Paralysis Resource Center website is supported by the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $8,700,000 with 100 percent funding by ACL/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACL/HHS, or the U.S. Government.